SRA1 antibody (truncated)
Quick Overview for SRA1 antibody (truncated) (ABIN2464107)
Target
See all SRA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- truncated
-
Immunogen
- Ni-NTA purified truncated recombinant SRA expressed in E. Coli strain BL21 (DE3).
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Western Blot:1:500 - 1:2,000
IHC(P):1:500 - 1:2,000
IHC(F):1:500 - 1:2,000
ELISA:Propose dilution 1:10,000
Determining optimal working dilutions by titration test. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
Storage
- -20 °C
-
Storage Comment
- SRA monoclonal antibody can be stored at -20 °C, stable for one year.
-
-
- SRA1 (Steroid Receptor RNA Activator 1 (SRA1))
-
Alternative Name
- SRA
-
Background
- Steroid receptor RNA activator 1 (SRA), with 237-amino acid protein (about 27 kDa), belongs to the growing family of functional non-coding RNAs. SRA was originally described as the first functional noncoding RNA able to specifically coactivate the activity of steroid receptors. Specifically, SRA exists as both an RNA transcript that forms a complex with steroid receptor coactivator-1 and as a stably expressed protein. Its expression is strongly up-regulated in many human tumors of the breast, uterus, and ovary, suggesting a potential role in pathogenesis. Although coactivation of steroid-dependent transcription by SRA is accompanied by a proliferative response, overexpression is not in itself sufficient to induce turmorigenesis.
-
Gene ID
- 10011
-
UniProt
- Q9HD15
-
Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
Target
-